首页> 外国专利> Novel Farnesyl Transferase Inhibitors, their Preparation and Pharmaceutical compositions containing them.

Novel Farnesyl Transferase Inhibitors, their Preparation and Pharmaceutical compositions containing them.

机译:新型法呢基转移酶抑制剂,其制备以及含有它们的药物组合物。

摘要

The new products of general formula (I) are summarized,Their preparation and pharmaceutical components containing them In general formula (I),Rrepresents: a radical of the general formula - (CH2) m-X1- (CH2) nZ, in which: X1 = single bond or O or S, m = 0 or 1, and n = 0, 1 or 2, the radicals CH2 they can be substituted by carboxy, alkoxy carbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, amino, alkylamino, dialkylamino and Z represents: carboxy; COOR4, (R4 = alkyl) or: CON (R 5) (R6) (R5 = H or alkyl, R6 = H or optionally substituted alkyl, or R5 = H or alkyl, and R6 = hydroxy, optionally substituted alkyloxyethyl, or amino, or: PO (OR7) 2 (R7 = H or alkyl),o: A radical - nh-co-t / (t = h or an alternative)or: unradical -CH2N =;R1 and R2 = hydrogen or halogen or tar, finally replaced tar, or R1 and R2 in the same position respectively form a heterocycle composed of 1 or 2 heteroatoms and replaced by wind, or R1 = hydrogen or halogen or tar, new asphalt, and R2 = sulfur group; R3 = hydrogen or halogen or tar, acyl, tar, asphalt, anthrax or hydrocarbon; X3 = OS or NH -.-Co -, methylene, ethylene, asphalt or 1, 1, 1, 1, cyclopropyl, e = or S. new products of general formula (I);They are inhibitors of metastasis, and have obvious anti-tumor and anti leukemia properties.
机译:概述了通式(I)的新产品,它们的制备和含有它们的药物成分在通式(I)中,R代表:通式-(CH 2)m -X 1-(CH 2)nZ的基团,其中: X1 =单键或O或S,m = 0或1,n = 0、1或2,它们的CH2基团可以被羧基,烷氧基羰基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,氨基,烷基氨基,二烷基氨基和Z取代代表:羧基; COOR4,(R4 =烷基)或:CON(R 5)(R6)(R5 = H或烷基,R6 = H或任选取代的烷基,或R5 = H或烷基,且R6 =羟基,任选取代的烷氧基乙基或氨基,或:PO(OR7)2(R7 = H或烷基),o:基团-nh-co-t /(t = h或另一种基团)或:非基团-CH2N =; R1和R2 =氢或卤素或最终被焦油取代的焦油,或在同一位置的R1和R2分别形成由1或2个杂原子组成的杂环,并被风取代,或R1 =氢或卤素或焦油,新沥青,R2 =硫基; R3 =氢或卤素或焦油,酰基,焦油,沥青,炭疽或碳氢化合物; X3 = OS或NH -.- Co-,亚甲基,乙烯,沥青或1,1,1,1,环丙基,e =或S。通式(I);它们是转移的抑制剂,并且具有明显的抗肿瘤和抗白血病特性。

著录项

  • 公开/公告号AR003143A1

    专利类型

  • 公开/公告日1998-07-08

    原文格式PDF

  • 申请/专利权人 RHONE-POULENC RORER S.A.;

    申请/专利号AR20100351196

  • 发明设计人

    申请日1996-07-10

  • 分类号C07D209/72;C07D409/12;A61K31;A61K31/40;A61K31/403;A61K31/404;A61K31/425;A61K31/427;A61P35;A61P43;C07D209/58;C07D277/22;C07D401/06;C07D401/12;C07D403/06;C07D405/12;C07D417/12;C07F9/572;

  • 国家 AR

  • 入库时间 2022-08-22 02:58:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号